| |
| |
|
| Insider
Information: |
Chai Christopher Y |
| Relationship: |
Director |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
35,129 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,565 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
35,129 |
|
|
| Total
Value |
$17,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Map Pharmaceuticals Inc |
MAPP |
SVP, Chief Financial O... |
2013-03-01 |
0 |
2009-02-09 |
0 |
Premium* |
|
|
Principia Biopharma Inc |
PRNB |
Chief Financial Officer |
2020-09-28 |
0 |
2020-09-28 |
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Director |
2021-08-11 |
35,129 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2008-05-20 |
5 |
A |
$9.49 |
$10,188 |
D/D |
1,074 |
1,074 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2008-11-20 |
5 |
A |
$2.13 |
$4,577 |
D/D |
2,154 |
3,228 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-05-20 |
5 |
A |
$2.64 |
$4,614 |
D/D |
1,751 |
4,979 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-11-20 |
5 |
A |
$2.70 |
$4,676 |
D/D |
1,730 |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-05-20 |
5 |
A |
$7.85 |
$4,778 |
D/D |
609 |
7,318 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-11-20 |
5 |
A |
$12.50 |
$4,811 |
D/D |
385 |
7,703 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2011-05-20 |
5 |
A |
$12.65 |
$5,122 |
D/D |
405 |
8,108 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2011-11-20 |
5 |
A |
$11.54 |
$5,252 |
D/D |
455 |
8,563 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-05-20 |
5 |
A |
$9.81 |
$5,424 |
D/D |
553 |
10,423 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-11-20 |
5 |
A |
$9.89 |
$5,501 |
D/D |
556 |
10,979 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-02-09 |
4 |
AS |
$13.00 |
$273 |
D/D |
(21) |
0 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-10-01 |
4 |
AS |
$10.26 |
$102,624 |
D/D |
(10,000) |
4,979 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-11-02 |
4 |
AS |
$8.07 |
$80,722 |
D/D |
(10,000) |
4,979 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-03-23 |
4 |
AS |
$16.72 |
$133,790 |
D/D |
(8,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-03-24 |
4 |
AS |
$16.47 |
$131,746 |
D/D |
(8,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-05-20 |
4 |
AS |
$14.77 |
$236,346 |
D/D |
(16,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-07-20 |
4 |
AS |
$12.42 |
$99,384 |
D/D |
(8,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-07-21 |
4 |
AS |
$13.00 |
$104,000 |
D/D |
(8,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-09-20 |
4 |
AS |
$14.05 |
$224,808 |
D/D |
(16,000) |
6,709 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2011-09-20 |
4 |
AS |
$15.38 |
$492,278 |
D/D |
(32,000) |
7,703 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-02-18 |
4 |
AS |
$63.86 |
$494,186 |
D/D |
(7,500) |
4,766 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-05-19 |
4 |
AS |
$65.10 |
$488,268 |
D/D |
(7,500) |
3,539 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Financial Officer |
• – – |
2020-08-18 |
4 |
AS |
$99.37 |
$745,240 |
D/D |
(7,500) |
3,539 |
0 |
% |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP & CFO |
• – – |
2012-01-26 |
4 |
D |
$13.84 |
$13,051 |
D/D |
(943) |
9,870 |
0 |
- |
|
| MAPP |
Map Pharmaceuticals Inc |
SVP, Chief Financial Officer |
• – – |
2013-01-25 |
4 |
D |
$24.75 |
$29,873 |
D/D |
(1,207) |
12,522 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
